UiPath vs Pegasystems
PATH and PEGA side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PATH and PEGA compare
UiPath is the larger company, worth 1.3 times as much as Pegasystems ($6.8B against $5.2B).
On earnings, UiPath is cheaper: it trades at 19.6× trailing earnings, against 19.9× for Pegasystems.
UiPath grew revenue faster over the last twelve months (15.0% versus 0.93% for Pegasystems).
UiPath keeps more of each dollar of sales as profit, with a net margin of 21.0% compared with 16.9% at Pegasystems.
Pegasystems pays a dividend yielding 0.37%; UiPath does not pay one.
Pegasystems scores higher on the StockData Score (20 against 14 for UiPath), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PATH | PEGA |
|---|---|---|
| Size and price | ||
| Market cap | $6.8B | $5.2B |
| Share price | $13.10 | $32.04 |
| Change, 1 year | −8.8% | −46.7% |
| Change, 5 years | −75.1% | −46.6% |
| Beta (5Y) | 1.58 | 1.44 |
| Employees | 3,981 | 5,598 |
| StockData Score | ||
| Total score | 14 | 20 (better) |
| Valuation score | 1 | 5 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 4 | 4 |
| Health score | 6 | 6 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 19.6× (better) | 19.9× |
| P/S | 4.0× | 3.0× (better) |
| P/B | 3.5× (better) | 9.6× |
| EV/EBITDA | 31.0× | 26.4× (better) |
| P/FCF | 18.8× | 11.9× (better) |
| FCF yield | 5.3% | 8.4% (better) |
| Fair value | $12.50 | $42.69 |
| Margin of safety | −4.8% | 25.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.0% (better) | 0.93% |
| Revenue growth, 5Y average | 21.5% (better) | 11.4% |
| Net income growth (TTM) | 1695% (better) | 6.0% |
| EPS growth (TTM) | 2133% (better) | 11.0% |
| Profitability | ||
| Gross margin | 82.6% (better) | 75.9% |
| Operating margin | 8.9% | 9.9% (better) |
| Net margin | 21.0% (better) | 16.9% |
| FCF margin | 21.1% | 25.3% (better) |
| Return on equity | 20.0% | 51.4% (better) |
| Return on invested capital | 34.7% | 71.4% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | – | 650× |
| Current ratio | 2.39 (better) | 1.04 |
| Altman Z-score | 4.71 | 6.33 (better) |
| Piotroski F-score | 8 (better) | 7 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.37% |
| Payout ratio | – | 6.9% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 11.8% |
| Buyback yield | 3.9% | 10.3% (better) |
| Shareholder yield | 3.9% | 10.6% (better) |
| Ownership | ||
| Held by institutions | 69.3% | 58.1% |
| Held by insiders | 28.5% | 50.9% |
| Insider net buying, 12 months | −$87.4M | −$19.6M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 26.2% | 11.9% |
Go deeper
- PATH stock overview
- PATH income statement
- PATH valuation and score
- PEGA stock overview
- PEGA income statement
- PEGA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.